Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio PR Newswire ST. PAUL, Minn., Jan. 21, 2025 ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with...
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...
ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.04 | 0.0519413063238 | 77.01 | 79.14 | 75.66 | 1011622 | 77.78145007 | CS |
| 4 | 4.56 | 6.29052283074 | 72.49 | 79.14 | 70.755 | 792115 | 75.21157781 | CS |
| 12 | 2.95 | 3.98110661269 | 74.1 | 79.86 | 65.61 | 869054 | 73.64592821 | CS |
| 26 | 0.26 | 0.338585753353 | 76.79 | 83.62 | 65.61 | 893271 | 74.22540902 | CS |
| 52 | 4.07 | 5.57687037545 | 72.98 | 85.57 | 61.16 | 983813 | 73.38895254 | CS |
| 156 | -14.17 | -15.5338741504 | 91.22 | 113.805 | 51.79 | 786070 | 75.78970255 | CS |
| 260 | 22.245 | 40.5893622845 | 54.805 | 135.9625 | 38.7925 | 558541 | 78.0471204 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
